(Q82268868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016481%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1 reference

title

'Allogeneic marrow transplantation in children with acute leukemia: a practice whose time has gone': twenty years later (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016481%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

D Pinkel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016481%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

1 reference

1 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016481%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016481%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016481%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016481%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

2189-2196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016481%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2009.132

15 January 2020

exact match

0 references

cites work

Bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Bone marrow transplantation: a review of delayed complications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Mar

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Treatment of children with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.132

7 January 2021